Regenerative medicine company IntelliCell BioSciences recently appointed James R. Andrew, MD, and Joshua Hackel, MD, both of Andrews Institute of Orthopaedic and Sports Medicine in Gulf Breeze, Fla., to its medical advisory board, according to a company news release.
Dr. Andrews and his team have conducted scientific exploration into IntelliCell BioSciences' technology with professional athletes and seen positive results. The two groups are also discussing the possibility of establishing an IntelliCell Center of Excellence at the Andrews Institute to conduct clinical research in the use of stormal vascular fracture cells manufactured with the company's proprietary non-enzymatic process.
Related Articles on Orthopedic Devices:
Exactech Begins Trial for Cartilage Repair Technology
Biomet Reports 2Q Net Sales Increase, but Spine Sales Down 5%
MedShape Receives Patent for Memory Technology
Related Articles on Orthopedic Devices:
Exactech Begins Trial for Cartilage Repair Technology
Biomet Reports 2Q Net Sales Increase, but Spine Sales Down 5%
MedShape Receives Patent for Memory Technology